Medifast (MED) Profit After Tax (2010 - 2026)

Medifast (MED) has 17 years of Profit After Tax data on file, last reported at -$2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax fell 174.87% year-over-year to -$2.1 million; the trailing twelve-month figure through Mar 2026 stood at -$20.0 million (down 186.19% YoY), and the FY2025 full-year result was -$18.7 million, down 992.97% from the prior year.
• Profit After Tax for Q1 2026 stood at -$2.1 million, up from -$18.1 million in the prior quarter.
• Across five years, Profit After Tax topped out at $41.8 million in Q1 2022 and bottomed at -$18.1 million in Q4 2025.
• The 5-year median for Profit After Tax is $6.0 million (2023), against an average of $13.2 million.
• Peak annual rise in Profit After Tax reached 130.41% in 2025, while the deepest fall reached 2362.05% in 2025.
• A 5-year view of Profit After Tax shows it stood at $26.5 million in 2022, then slumped by 77.24% to $6.0 million in 2023, then slumped by 86.73% to $801000.0 in 2024, then sank by 2362.05% to -$18.1 million in 2025, then jumped by 88.29% to -$2.1 million in 2026.
• The last three Profit After Tax figures came in at -$2.1 million (Q1 2026), -$18.1 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.

Peer Comparison